Lite Strategy, Inc. (LITS)
NASDAQ: LITS · Real-Time Price · USD
2.800
+0.090 (3.32%)
Sep 19, 2025, 4:00 PM EDT - Market closed
Lite Strategy Employees
Lite Strategy had 28 employees as of June 30, 2024. The number of employees decreased by 18 or -39.13% compared to the previous year.
Employees
28
Change (1Y)
-18
Growth (1Y)
-39.13%
Revenue / Employee
n/a
Profits / Employee
-$1,130,821
Market Cap
96.41M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
LITS News
- 10 days ago - MEI Pharma, Inc. Rebrands as Lite Strategy, Inc., Adopts New NASDAQ Ticker ‘LITS' - Business Wire
- 6 weeks ago - MEI Pharma Acquires Litecoin, Launches $100M Institutional Treasury Strategy with Charlie Lee and GSR Advising - Business Wire
- 2 months ago - BTC digital asset field continues to exert its strength, HASHJ launches Bitcoin cloud mining platform with "capital + technology" dual-driven mode - TheNewswire
- 2 months ago - MEI Pharma Announces Closing of $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange - Business Wire
- 2 months ago - Why Is MEI Pharma Stock Soaring On Friday? - Benzinga
- 2 months ago - MEI Pharma Announces $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange - Business Wire
- 4 months ago - MEI Pharma Reports Third Quarter Fiscal Year 2025 Cash Position - Business Wire
- 7 months ago - MEI Pharma Reports Second Quarter Fiscal Year 2025 Cash Position - Business Wire